Document is current
Any future updates will be listed below
-
Authors
Riedemann, Lars
Labonne, Maxime
Gilbert, Stephen
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (16KISA100K)
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 14 November 2024
First Online: 27 November 2024
Competing interests
: L.R. declares shares in Shift Medical GmbH. M.L. is a Senior Staff Machine Learning Scientist for Liquid AI, Inc. S.G. declares a nonfinancial interest as an Advisory Group member of the EY-coordinated “Study on Regulatory Governance and Innovation in the field of Medical Devices” conducted on behalf of the Directorate-General for Health and Food Safety (SANTE) of the European Commission. S.G. declares the following competing financial interests: he has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd., Flo Ltd, ICURA ApS, Rock Health Inc., Thymia Ltd., FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, Directorate-General for Research and Innovation Of the European Commission, and Ada Health GmbH and holds share options in Ada Health GmbH. S.G. is a News and Views Editor for npj Digital Medicine. S.G. played no role in the internal review or decision to publish this News and Views article.
